Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02005614
What this trial is testing

A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection

Who this might be right for
MelanomaRenal Cell CarcinomaSarcoma+5 more
Yale University 39
Testing effectiveness (Phase 2)Study completedNCT01289821
What this trial is testing

First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib

Who this might be right for
Colorectal Neoplasms
Bayer 54
Testing effectiveness (Phase 2)UnknownNCT00057395
What this trial is testing

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Who this might be right for
Esophageal NeoplasmsHepatocellular CarcinomaColorectal Neoplasms+3 more
Aronex Pharmaceuticals 40
Not applicableAvailableNCT04566393
What this trial is testing

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Who this might be right for
Pancreatic CancerSmall Bowel CancerColorectal Cancer+18 more
xCures
Testing effectiveness (Phase 2)Active Not RecruitingNCT03087071
What this trial is testing

Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
EGFR NP_005219.2:p.S492RKRAS Gene MutationMAP2K1 Gene Mutation+5 more
M.D. Anderson Cancer Center 59
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT05726864
What this trial is testing

ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerKRAS G12D+11 more
Elicio Therapeutics 158
Not applicableUnknownNCT04917263
What this trial is testing

IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment.

Who this might be right for
Rectal Cancer
University of Padova 544
Early research (Phase 1)Study completedNCT00959127
What this trial is testing

ARRY-438162 (MEK162) in Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorsAdvanced or Metastatic Biliary CancerMetastatic Colorectal Cancer
Array Biopharma, now a wholly owned subsidiary of Pfizer 93
Large-scale testing (Phase 3)Study completedNCT00056459
What this trial is testing

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal NeoplasmsColonic NeoplasmsRectal Neoplasms
Novartis 1,168
Not applicableLooking for participantsNCT06536127
What this trial is testing

Prospective Monocentric Study Evaluating the Circulating NK Cells Phenotype and the ImmunoScore® in Patients With Non Metastatic Rectal Cancer

Who this might be right for
Rectal CancerNon Metastatic Cancer
Institut Sainte Catherine 100
Early research (Phase 1)Active Not RecruitingNCT06462183
What this trial is testing

Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)

Who this might be right for
Adenoid Cystic CarcinomaColorectal Cancer
Rgenta Therapeutics Inc 105
Early research (Phase 1)Active Not RecruitingNCT05783622
What this trial is testing

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+4 more
Janux Therapeutics 130
Testing effectiveness (Phase 2)Looking for participantsNCT06205836
What this trial is testing

Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44
Not applicableStudy completedNCT03506321
What this trial is testing

Comparison of the Benefit of Chromoendoscopy in Addition to High Definition White Light and Narrow Band Imaging for the Prediction of Submucosal Invasive Cancer in Colonic Lesions

Who this might be right for
Colonic AdenomaColon PolypSubmucosal Invasive Colon Adenocarcinoma+1 more
Western Sydney Local Health District 400
Large-scale testing (Phase 3)Study completedNCT00392899
What this trial is testing

Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery

Who this might be right for
Colorectal Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2,025
Testing effectiveness (Phase 2)Study completedNCT03584711
What this trial is testing

FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation

Who this might be right for
Metastatic Colorectal Cancer
Federation Francophone de Cancerologie Digestive 118
Large-scale testing (Phase 3)Ended earlyNCT00720512
What this trial is testing

Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab

Who this might be right for
Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 184
Testing effectiveness (Phase 2)Study completedNCT00321685
What this trial is testing

Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer

Who this might be right for
Rectal AdenocarcinomaStage II Rectal Cancer AJCC v7Stage III Rectal Cancer AJCC v7
National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)Ended earlyNCT03170115
What this trial is testing

Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer

Who this might be right for
Rectal Cancer, AdenocarcinomaLocally Advanced Malignant NeoplasmChemoradiation
Instituto Nacional de Cancer, Brazil 25
Next Page